Skip Navigation LinksHome > March 2012 - Volume 34 - Issue 2 > Is There a Need for Dedicated Bone Imaging in Addition to 18...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3182282825
Original Articles

Is There a Need for Dedicated Bone Imaging in Addition to 18F-FDG PET/CT Imaging in Pediatric Sarcoma Patients?

Walter, Franziska MD*,†; Czernin, Johannes MD*,†; Hall, Theodore MD; Allen-Auerbach, Martin MD*,†; Walter, Martin A. MD§; Dunkelmann, Simone MD; Federman, Noah MD

Collapse Box

Abstract

Purpose: Many children with sarcomas undergo whole body 2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) and technetium methylene diphosphonate (99Tc-MDP) studies. It is unknown whether the combination of both tests results in more accurate detection of bone lesions than 18F-FDG- PET/CT alone.

Methods: 99Tc-MDP bone and 18F-FDG PET/CT scans were each read by 2 “blinded” observers and then reviewed side-by-side by 3 readers. Bone lesions were graded qualitatively on a 5-point scale (from benign to malignant). Clinical and imaging follow-up (n=21) and bone biopsy results (n=8) served as reference standard.

Results: A total of 39 paired 99Tc-MDP and 18F-FDG-PET/CT studies (cases) performed at a mean interval 4±7 days, were performed on 29 patients (mean age 12±5 y). Of these, 21 patients (72%) had bone sarcoma, whereas 8 patients (28%) had soft tissue sarcoma. By patient and case-based analysis, 18F-FDG PET/CT had an accuracy of 100%. 99Tc-MDP had accuracies of 90% and 82% by patient and case-based analysis. The combined interpretation had an accuracy of 97%.

Conclusions: In this study, 99Tc-MDP bone imaging does not provide an added diagnostic value for bone involvement over 18F-FDG-PET/CT.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/JPHOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.